Lymph node-independent liver metastasis in a model of metastatic colorectal cancer

Nature Communications

Volumn 5, Issue , 2014, Pages

  Enquist, Ida B ^a   Good, Zinaida ^a   Jubb, Adrian M ^a   Fuh, Germaine ^a   Wang, Xi ^a   Junttila, Melissa R ^a   Jackson, Erica L ^a   Leong, Kevin G ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; COLONIZATION; DATA SET; HEMATOLOGY; MORTALITY; NUMERICAL MODEL; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER MODEL; CANCER TRANSPLANTATION; CARCINOGENESIS; CARCINOMATOUS PERITONITIS; CECUM; COLON MUCOSA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MESENTERY LYMPH NODE; METASTATIC COLORECTAL CANCER; MOUSE; MOUSE MODEL; NONHUMAN; TARGET ORGAN; TUMOR INVASION; ANIMAL; ANTAGONISTS AND INHIBITORS; CARCINOMA; COLON; COLORECTAL TUMOR; DISEASE MODEL; DRUG EFFECTS; HCT116 CELL LINE; LIVER TUMOR; LYMPH NODE; METASTASIS; PATHOLOGY; PERITONEUM TUMOR; SECONDARY;

ANGIOGENESIS INHIBITOR; VASCULOTROPIN C;

ANGIOGENESIS INHIBITORS; ANIMALS; CARCINOMA; CECUM; COLON; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; HCT116 CELLS; HUMANS; LIVER NEOPLASMS; LYMPH NODES; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MICE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PERITONEAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84897065412     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4530     Document Type: Article

References (45)

1. Bacac, M. & Stamenkovic, I. Metastatic cancer cell. Annu. Rev. Pathol. 3, 221-247 (2008).
2. Heijstek, M. W., Kranenburg, O. & Borel Rinkes, I. H. Mouse models of colorectal cancer and liver metastases. Dig. Surg. 22, 16-25 (2005).
3. Kobaek-Larsen, M., Thorup, I., Diederichsen, A., Fenger, C. & Hoitinga, M. R. Review of colorectal cancer and its metastases in rodent models: comparative aspects with those in humans. Comp. Med. 50, 16-26 (2000).
4. Rosenberg, D. W., Giardina, C. & Tanaka, T. Mouse models for the study of colon carcinogenesis. Carcinogenesis 30, 183-196 (2009).
5. Taketo, M. M. & Edelmann, W. Mouse models of colon cancer. Gastroenterology 136, 780-798 (2009).
6. Su, L. K. et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668-670 (1992).
7. Moser, A. R., Pitot, H. C. & Dove, W. F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322-324 (1990).
8. Janssen, K. P. et al. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Gastroenterology 131, 1096-1109 (2006).
9. Luo, F. et al. Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways. Int. J. Exp. Pathol. 90, 558-574 (2009).
10. Haigis, K. M. et al. Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nat. Genet. 40, 600-608 (2008).
11. Sansom, O. J. et al. Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo. Proc. Natl Acad. Sci. USA 103, 14122-14127 (2006).
12. Hung, K. E. et al. Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment. Proc. Natl Acad. Sci. USA 107, 1565-1570 (2010).
13. Donigan, M. et al. A metastatic colon cancer model using nonoperative transanal rectal injection. Surg. Endosc. 24, 642-647 (2010).
14. Cespedes, M. V. et al. Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites. Am. J. Pathol. 170, 1077-1085 (2007).
15. Bhullar, J. S. et al. A novel nonoperative orthotopic colorectal cancer murine model using electrocoagulation. J. Am. Coll. Surg. 213, 54-60, discussion 60-61 (2011).
16. Fu, X. Y., Besterman, J. M., Monosov, A. & Hoffman, R. M. Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc. Natl Acad. Sci. USA 88, 9345-9349 (1991).
17. Jin, H. et al. A superficial colon tumor model involving subcutaneous colon translocation and orthotopic transplantation of green fluorescent proteinexpressing human colon tumor. Tumour Biol. 32, 391-397 (2011).
18. Klaver, Y. L., Lemmens, V. E., Nienhuijs, S. W., Luyer, M. D. & de Hingh, I. H. Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options. World J. Gastroenterol. 18, 5489-5494 (2012).
19. Jellema, P. et al. Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis. BMJ 340, c1269 (2010).
20. Fidler, I. J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 3, 453-458 (2003).
21. Chambers, A. F., Groom, A. C. & MacDonald, I. C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2, 563-572 (2002).
22. Ikoma, N. et al. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model. Oncol. Rep. 14, 633-637 (2005).
23. Quintana, E. et al. Efficient tumour formation by single human melanoma cells. Nature 456, 593-598 (2008).
24. Cohen, S. J. et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J. Clin. Oncol. 26, 3213-3221 (2008).
25. Schwartz, R. N. Management of early and advanced colorectal cancer: therapeutic issues. Am. J. Health Syst. Pharm. 65, S8-S14 (2008).
26. Derwinger, K. & Gustavsson, B. A study of lymph node ratio in stage IV colorectal cancer. World J. Surg. Oncol. 6, 127 (2008).
27. Saad, R. S. et al. Lymphatic microvessel density as prognostic marker in colorectal cancer. Mod. Pathol. 19, 1317-1323 (2006).
28. Saharinen, P., Tammela, T., Karkkainen, M. J. & Alitalo, K. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol. 25, 387-395 (2004).
29. Prandi, M. et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann. Surg. 235, 458-463 (2002).
30. Tsikitis, V. L. et al. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved. J. Am. Coll. Surg. 208, 42-47 (2009).
31. Wong, S. L. et al. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA 298, 2149-2154 (2007).
32. Suzuki, A. et al. Evaluation of venous invasion by Elastica van Gieson stain and tumor budding predicts local and distant metastases in patients with T1 stage colorectal cancer. Am. J. Surg. Pathol. 33, 1601-1607 (2009).
33. Carmeliet, P. & Jain, R. K. Molecular mechanisms and clinical applications of angiogenesis. Nature 473, 298-307 (2011).
34. Adams, R. H. & Alitalo, K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 8, 464-478 (2007).
35. Oh, S. J. et al. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev. Biol. 188, 96-109 (1997).
36. Liang, W. C. et al. Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF. J. Biol. Chem. 281, 951-961 (2006).
37. Gogineni, A. et al. Inhibition of VEGF-C modulates distal lymphatic remodeling and secondary metastasis. PLoS One 8, e68755 (2013).
38. Niki, T. et al. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin. Cancer Res. 6, 2431-2439 (2000).
39. Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A. & Ferrara, N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest. 95, 1789-1797 (1995).
40. Ganepola, G. A. et al. Gene expression profiling of primary and metastatic colon cancers identifies a reduced proliferative rate in metastatic tumors. Clin. Exp. Metastasis 27, 1-9 (2010).
41. Koh, K. H. et al. Differential gene expression profiles of metastases in paired primary and metastatic colorectal carcinomas. Oncology 75, 92-101 (2008).
42. Lan, H. et al. Heterogeneity between primary colon carcinoma and paired lymphatic and hepatic metastases. Mol. Med. Rep. 6, 1057-1068 (2012).
43. Vermaat, J. S. et al. Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment. Clin. Cancer Res. 18, 688-699 (2012).
44. Lee, C. V. et al. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold. J. Mol. Biol. 340, 1073-1093 (2004).
45. Lee, C. V. et al. Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells. Blood 108, 3103-3111 (2006).